DRUG · Mapped RxNorm record
Enoxaparin
Normalized identity: enoxaparinView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Comparing Anti-XA Levels in Post-Cesarean Patients Undergoing Enoxaparin Thromboprophylaxis
NCT02070237
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedComparing Anti-XA Levels in Post-Cesarean Patients Undergoing Enoxaparin Thromboprophylaxis
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Obesityverified · MONDO: obesity disorder
Obesity, Morbidcandidate · MONDO: morbid obesity
Pregnancyunresolved
Complications; Cesarean Sectionunresolved
Postpartum Deep Phlebothrombosisunresolved
Pulmonary Embolismverified · MONDO: pulmonary embolism
Interventions
EnoxaparinDRUG · verified · RxNorm: enoxaparin
Sponsors & collaborators
MemorialCare Health Systemlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02070237 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.